NGL Fine-Chem Limited (BOM:524774)
India · Delayed Price · Currency is INR 2,925.50
+17.10 (0.59%)
At close: Oct 1, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 18.07 billion as of October 2, 2026. Its market cap has increased by 106.23% in one year.
Market Cap
18.07B
Enterprise Value
18.86B
Revenue
5.36B
Ranking
n/a
PE Ratio
31.55
Stock Price
2,925.50
ChartMarket Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 18.07B, an increase of 22,379.86%. That is a compound annual growth rate of 28.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 18.07B | 107.63% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suven Life Sciences | 90.42B |
| Symbiotec Pharmalab | 75.61B |
| IOL Chemicals and Pharmaceuticals | 60.82B |
| Gujarat Themis Biosyn | 50.47B |
| Bajaj HealthCare | 10.98B |
| Shree Ganesh Remedies | 8.81B |
| Influx Healthtech | 6.02B |
| Aarey Drugs & Pharmaceuticals | 2.92B |